Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

نویسندگان

  • Robert J Adams
  • Greg Albers
  • Mark J Alberts
  • Oscar Benavente
  • Karen Furie
  • Larry B Goldstein
  • Philip Gorelick
  • Jonathan Halperin
  • Robert Harbaugh
  • S Claiborne Johnston
  • Irene Katzan
  • Margaret Kelly-Hayes
  • Edgar J Kenton
  • Michael Marks
  • Ralph L Sacco
  • Lee H Schwamm
چکیده

Robert J. Adams, MS, MD, FAHA, Chair; Greg Albers, MD; Mark J. Alberts, MD, FAHA; Oscar Benavente, MD; Karen Furie, MD, MPH, FAHA; Larry B. Goldstein, MD, FAHA, FAAN; Philip Gorelick, MD, MPH, FAHA, FAAN; Jonathan Halperin, MD, FAHA; Robert Harbaugh, MD, FACS, FAHA; S. Claiborne Johnston, MD, PhD; Irene Katzan, MD, MS, FAHA; Margaret Kelly-Hayes, RN, EdD, FAHA; Edgar J. Kenton, MD, FAHA, FAAN; Michael Marks, MD; Ralph L. Sacco, MS, MD, FAHA, FAAN; Lee H. Schwamm, MD, FAHA

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

AHA and ASA Release Guideline for Prevention of Future Stroke in Patients with Stroke or TIA.

www.aafp.org/afp Volume 91, Number 2 ◆ January 15, 2015 The American Heart Association (AHA) and American Stroke Association (ASA) have updated their guideline on prevention of future stroke in patients with a history of stroke or transient ischemic attack (TIA). Currently, the average annual rate of future stroke in these patients is at a historic low. This is a result of new approaches and im...

متن کامل

AHA/ASA publish advisory on oral antithrombotics for stroke prevention in nonvalvular artial fibrillation.

www.aafp.org/afp Volume 87, Number 10 ◆ May 15, 2013 Among adults with atrial fibrillation, the annual rate of stroke ranges from 1 to 20 percent, depending on comorbidities and the patient’s history of cerebrovascular events. Because of the risk of bleeding associated with antithrombotics such as warfarin (Coumadin) that are used to reduce the incidence of atrial fibrillation–related stroke, i...

متن کامل

Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.

The rate of stroke among adults with atrial fibrillation (AF) varies widely, ranging between 1% and 20% annually (mean 4.5% per year) depending on comorbidities and a patient’s history of prior cerebrovascular events. Stratification of stroke risk is important, because the major risk of antithrombotic medications used to lower the incidence of AFrelated stroke is bleeding. For warfarin, this in...

متن کامل

AHA/ASA Guidelines on Prevention of Recurrent Stroke

Volume 83, Number 8 www.aafp.org/afp American Family Physician 993 Persons who survive a stroke or transient ischemic attack (TIA) are at increased risk of experiencing another stroke. In the United States, about one-fourth of the nearly 800,000 strokes that occur each year are recurrent events. The risk of stroke within 90 days of a TIA may be as high as 17 percent, with the greatest risk duri...

متن کامل

Study of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke

Introduction: Ischemic stroke is amongst the top four causes of mortality and the leading cause of disability in the world. The aim of this study was to evaluate the efficacy of a high dose memantine on neurological function of patients with ischemic stroke.Methods: In a randomized, 2 armed, open-label study, patients with mild to moderate cerebral thromboembolic event (CTEE) who admitted to Im...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Stroke

دوره 39 5  شماره 

صفحات  -

تاریخ انتشار 2008